Expiring federal contract · order under a contract vehicle
36C25526N0159 — Jubilant Draximage Radiopharmacies, INC.
Department of Veterans Affairs
- Contract / PIID
- 36C25526N0159
- Incumbent
- Jubilant Draximage Radiopharmacies, INC.
- Incumbent UEI
- ZL79MXYVNDM1
- Current end date
- January 31, 2027
- Potential total value
- $439,477
- Obligated
- $439,477
- NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- Set-aside
- Not stated
- Start date
- February 1, 2026
- Place of performance
- MO
- Award type
- DELIVERY ORDER
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
RADIOPHARMACEUTICALS KC VAMC
Likely rebid window (estimate)
- Sources Sought / RFI: about Jan 2026 – Jul 2026 (6–12 months before the end date)
- RFP: about Sep 2026 – Nov 2026 (2–4 months before the end date)
Now inside the estimated RFP window.
This is an order under contract vehicle 36C25525D0032. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Veterans Affairs (NAICS 325412)
- 36C24126F0039 — Medi-physics, INC. · ends November 21, 2026 · $100K
- 36C25026N0181 — Schaaf Drugs, LLC · ends November 22, 2026 · $681K
- 36C24626N0323 — Cardinal Health 414, LLC · ends November 30, 2026 · $323K
- 36C25226P0101 — Petnet Solutions, INC. · ends November 30, 2026 · $110K
- 36C26023P0532 — Cardinal Health 414, LLC · ends November 30, 2026 · $337K
- 36C26224P0297 — Rls (USA) INC. · ends November 30, 2026 · $1.1M
- 36C26226N0112 — Novartis Pharmaceuticals Corporation · ends November 30, 2026 · $4.3M
- 36C26227N0156 — Novartis Pharmaceuticals Corporation · ends November 30, 2026 · $769K
- 36C24726F0053 — Exelan Pharmaceuticals INC · ends December 7, 2026 · $4.8M
- 36C24126P0074 — Trillamed LLC · ends December 10, 2026 · $927K